For World Asthma Day, GINA released its 2025 guidelines update and joined in a campaign to make inhaled asthma therapies more ...

Patients with severe asthma (4.6% of asthma patients) are more likely to be female, older, and have higher BMI than those with non-severe asthma.

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of life for patients. These devices range from inhalers to ...

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

for patients with asthma and chronic obstructive pulmonary disease (COPD). Teva noted it is the first and only digital rescue inhaler indicated in patients four years or older for the treatment ...

Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling First patient dosed in Phase 1b trial of APG777 in mild- ...

Such a warning looms large in Tampa, where census data show that more than 50,000 residents are over the age of 65, and an ...